Article
A CHRNA5 Smoking Risk Variant Decreases the Aversive Effects of Nicotine in Humans.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology - 1 Nov 2015
Jensen Kevin P, DeVito Elise E, Herman Aryeh I, Valentine Gerald W, Gelernter Joel, Sofuoglu Mehmet
Abstract excerpt
Genome-wide association studies have implicated the CHRNA5-CHRNA3-CHRNB4 gene cluster in risk for heavy smoking and several smoking-related disorders. The heavy smoking risk allele might reduce the aversive effects of nicotine, but this hypothesis has not been tested in humans. We evaluated the effects of a candidate causal variant in CHRNA5, rs16969968, on the acute response to nicotine in European American (EA)...
Topics
Join the communities discussing this publication.
